MoneyWorks4Me

SMS Pharmaceuticals informs about 32nd annual report

08 Sep 2020 Evaluate

Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has submitted the soft copy of the Annual Report of the Company for the Financial Year 2019-20. The 32nd Annual General Meeting of the Company scheduled on 30th September, 2020 to be held through Video Conferencing (VC) / Other Audio Visual Means (OAVM).

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..